AU2001289617A1 - Diagnosis of diseases associated with signal transduction - Google Patents
Diagnosis of diseases associated with signal transductionInfo
- Publication number
- AU2001289617A1 AU2001289617A1 AU2001289617A AU8961701A AU2001289617A1 AU 2001289617 A1 AU2001289617 A1 AU 2001289617A1 AU 2001289617 A AU2001289617 A AU 2001289617A AU 8961701 A AU8961701 A AU 8961701A AU 2001289617 A1 AU2001289617 A1 AU 2001289617A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- signal transduction
- diseases associated
- diseases
- transduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/125—Bisulfite(s)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10032529.7 | 2000-06-30 | ||
DE10032529A DE10032529A1 (de) | 2000-06-30 | 2000-06-30 | Diagnose von bedeutenden genetischen Parametern innerhalb des Major Histocompatibility Complex (MHC) |
DE10043826.1 | 2000-09-01 | ||
DE10043826 | 2000-09-01 | ||
PCT/EP2001/007472 WO2002000926A2 (fr) | 2000-06-30 | 2001-06-29 | Diagnostic de maladies associees a une transduction de signal |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001289617A1 true AU2001289617A1 (en) | 2002-01-08 |
Family
ID=26006285
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001277521A Abandoned AU2001277521A1 (en) | 2000-06-30 | 2001-06-29 | Diagnosis of diseases associated with cell signalling |
AU2001289617A Abandoned AU2001289617A1 (en) | 2000-06-30 | 2001-06-29 | Diagnosis of diseases associated with signal transduction |
AU2001276371A Abandoned AU2001276371A1 (en) | 2000-06-30 | 2001-06-29 | Method and nucleic acids for analysing the methylation of genes implicated pharmacogenomics |
AU2001287576A Abandoned AU2001287576A1 (en) | 2000-06-30 | 2001-07-02 | Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells |
AU2001283915A Abandoned AU2001283915A1 (en) | 2000-06-30 | 2001-07-02 | Diagnosis of diseases associated with development by means of assessing their methylation status |
AU2001279707A Abandoned AU2001279707A1 (en) | 2000-06-30 | 2001-07-02 | Diagnosis of behavioural disorders, neurological disorders and cancer |
AU2001287575A Abandoned AU2001287575A1 (en) | 2000-06-30 | 2001-07-02 | Diagnosis of diseases associated with the immune system by determining cytosine methylation |
AU2001283916A Abandoned AU2001283916A1 (en) | 2000-06-30 | 2001-07-02 | Method and nucleic acids for the analysis of astrocytomas |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001277521A Abandoned AU2001277521A1 (en) | 2000-06-30 | 2001-06-29 | Diagnosis of diseases associated with cell signalling |
Family Applications After (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001276371A Abandoned AU2001276371A1 (en) | 2000-06-30 | 2001-06-29 | Method and nucleic acids for analysing the methylation of genes implicated pharmacogenomics |
AU2001287576A Abandoned AU2001287576A1 (en) | 2000-06-30 | 2001-07-02 | Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells |
AU2001283915A Abandoned AU2001283915A1 (en) | 2000-06-30 | 2001-07-02 | Diagnosis of diseases associated with development by means of assessing their methylation status |
AU2001279707A Abandoned AU2001279707A1 (en) | 2000-06-30 | 2001-07-02 | Diagnosis of behavioural disorders, neurological disorders and cancer |
AU2001287575A Abandoned AU2001287575A1 (en) | 2000-06-30 | 2001-07-02 | Diagnosis of diseases associated with the immune system by determining cytosine methylation |
AU2001283916A Abandoned AU2001283916A1 (en) | 2000-06-30 | 2001-07-02 | Method and nucleic acids for the analysis of astrocytomas |
Country Status (5)
Country | Link |
---|---|
US (5) | US20040023230A1 (fr) |
EP (9) | EP1297185A2 (fr) |
JP (1) | JP2004501666A (fr) |
AU (8) | AU2001277521A1 (fr) |
WO (8) | WO2002002806A2 (fr) |
Families Citing this family (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7285267B2 (en) | 1997-01-14 | 2007-10-23 | Human Genome Sciences, Inc. | Tumor necrosis factor receptors 6α & 6β |
ATE365796T1 (de) | 1997-01-14 | 2007-07-15 | Human Genome Sciences Inc | Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta |
US6818404B2 (en) | 1997-10-23 | 2004-11-16 | Exact Sciences Corporation | Methods for detecting hypermethylated nucleic acid in heterogeneous biological samples |
US7611869B2 (en) * | 2000-02-07 | 2009-11-03 | Illumina, Inc. | Multiplexed methylation detection methods |
US7582420B2 (en) | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
US8076063B2 (en) * | 2000-02-07 | 2011-12-13 | Illumina, Inc. | Multiplexed methylation detection methods |
US7955794B2 (en) | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
WO2001092565A2 (fr) | 2000-04-06 | 2001-12-06 | Epigenomics Ag | Diagnostic de maladies associees a une transcription adn |
WO2002004686A2 (fr) * | 2000-07-10 | 2002-01-17 | Epigenx Pharmaceutical, Inc. | Detection de la cytosine methylee dans des polynucleotides |
JP2002034575A (ja) * | 2000-07-28 | 2002-02-05 | Shiseido Co Ltd | ヒトII型5α−レダクターゼのプロモーター遺伝子およびその用途 |
DE10054974A1 (de) * | 2000-11-06 | 2002-06-06 | Epigenomics Ag | Diagnose von mit Cdk4 assoziierten Krankheiten |
DE10061338A1 (de) * | 2000-12-06 | 2002-06-20 | Epigenomics Ag | Diagnose von mit Angiogenese assoziierten Krankheiten |
US6756200B2 (en) * | 2001-01-26 | 2004-06-29 | The Johns Hopkins University School Of Medicine | Aberrantly methylated genes as markers of breast malignancy |
WO2002077895A2 (fr) * | 2001-03-26 | 2002-10-03 | Epigenomics Ag | Procede de selection d'aspects epigenetiques |
EP2280030A3 (fr) | 2001-04-10 | 2011-06-15 | Agensys, Inc. | Acides nucléiques et protéines correspondantes utiles dans la détection et le traitement des différents cancers |
US7235358B2 (en) | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
DE10128508A1 (de) | 2001-06-14 | 2003-02-06 | Epigenomics Ag | Verfahren und Nukleinsäuren für die Differenzierung von Prostata-Tumoren |
US7432050B2 (en) | 2001-10-05 | 2008-10-07 | Case Western Reserve University | Methods and compositions for detecting colon cancers |
US20110151438A9 (en) * | 2001-11-19 | 2011-06-23 | Affymetrix, Inc. | Methods of Analysis of Methylation |
WO2003062441A1 (fr) * | 2002-01-18 | 2003-07-31 | Genzyme Corporation | Procedes de detection d'adn foetal et de quantification d'alleles |
WO2003064700A2 (fr) * | 2002-01-30 | 2003-08-07 | Epigenomics Ag | Identification d'etats de differentiation cellulaire |
EP1340818A1 (fr) | 2002-02-27 | 2003-09-03 | Epigenomics AG | Procédés et acides nucléiques pour l'analyse d'un trouble associé à la prolifération de cellules du colon |
WO2003076593A2 (fr) * | 2002-03-07 | 2003-09-18 | The Johns Hopkins University School Of Medicine | Depistage genomique pour genes lies au cancer rendus epigenetiquement silencieux |
JP2005532067A (ja) * | 2002-07-03 | 2005-10-27 | コーリー ファーマシューティカル グループ,インコーポレイテッド | 刺激性免疫応答用の核酸組成物 |
US7605138B2 (en) * | 2002-07-03 | 2009-10-20 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US7807803B2 (en) | 2002-07-03 | 2010-10-05 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US20040053880A1 (en) | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US20040029128A1 (en) * | 2002-08-08 | 2004-02-12 | Epigenomics, Inc. | Methods and nucleic acids for the analysis of CpG dinucleotide methylation status associated with the calcitonin gene |
EP1554407B1 (fr) | 2002-10-01 | 2009-07-29 | Epigenomics AG | Procede en vue du traitement de troubles de la proliferation de celllules mammaires |
US20060094016A1 (en) * | 2002-12-02 | 2006-05-04 | Niall Gormley | Determination of methylation of nucleic acid sequences |
WO2004087044A2 (fr) * | 2002-12-20 | 2004-10-14 | Bioseek, Inc. | Cible medicamenteuse |
ITRM20030149A1 (it) | 2003-04-02 | 2004-10-03 | Giuliani Spa | Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico |
US20050009059A1 (en) * | 2003-05-07 | 2005-01-13 | Affymetrix, Inc. | Analysis of methylation status using oligonucleotide arrays |
US7430335B2 (en) | 2003-08-13 | 2008-09-30 | Apple Inc | Pre-processing method and system for data reduction of video sequences and bit rate reduction of compressed video sequences using spatial filtering |
US7403568B2 (en) | 2003-08-13 | 2008-07-22 | Apple Inc. | Pre-processing method and system for data reduction of video sequences and bit rate reduction of compressed video sequences using temporal filtering |
EP1692264A2 (fr) * | 2003-10-28 | 2006-08-23 | The Johns Hopkins University | Pcr quantitative multiplex specifique de la methylation |
WO2005054517A2 (fr) * | 2003-12-01 | 2005-06-16 | Epigenomics Ag | Procedes et acides nucleiques pour l'analyse de l'expression genique associee a la survenue de troubles cellulaires proliferants de la prostate |
EP1561821B1 (fr) | 2003-12-11 | 2011-02-16 | Epigenomics AG | Marqueurs pour le pronostic de la réponse à la thérapie et/ou de la survie chez les patients du cancer du sein |
EP2471924A1 (fr) * | 2004-05-28 | 2012-07-04 | Asuragen, INC. | Procédés et compositions impliquant du microARN |
EP2302073A1 (fr) * | 2004-07-18 | 2011-03-30 | Epigenomics AG | Procédés épigénétiques et acides nucléiques pour la détection de troubles cellulaires proliférables du sein |
US20080171318A1 (en) * | 2004-09-30 | 2008-07-17 | Epigenomics Ag | Epigenetic Methods and Nucleic Acids for the Detection of Lung Cell Proliferative Disorders |
EP2302055B1 (fr) | 2004-11-12 | 2014-08-27 | Asuragen, Inc. | Procédés et compositions impliquant l'ARNmi et des molécules inhibitrices de l'ARNmi |
US20060134650A1 (en) * | 2004-12-21 | 2006-06-22 | Illumina, Inc. | Methylation-sensitive restriction enzyme endonuclease method of whole genome methylation analysis |
WO2006088978A1 (fr) | 2005-02-16 | 2006-08-24 | Epigenomics, Inc. | Procede de determination du modele de methylation d'un acide polynucleique |
EP1748080A3 (fr) * | 2005-03-11 | 2007-04-11 | Epiontis GmbH | L'ADN spécifique pour la caractérisation epigénétique de cellules et tissus |
EP2402461B1 (fr) | 2005-03-11 | 2015-08-12 | Epiontis GmbH | Méthode et kit pour l'identification des chondrocytes par la détection de la deméthylation du gène C15orf27 |
JP5133238B2 (ja) | 2005-04-15 | 2013-01-30 | エピゲノミックス アクチェンゲゼルシャフト | 遠隔サンプル由来のdna断片を提供する方法 |
WO2006111586A2 (fr) * | 2005-04-20 | 2006-10-26 | Proyecto De Biomedicina Cima, S.L. | Procede permettant de determiner in vitro le degre de methylation du promoteur de line-1 |
US20060292585A1 (en) * | 2005-06-24 | 2006-12-28 | Affymetrix, Inc. | Analysis of methylation using nucleic acid arrays |
WO2007003397A2 (fr) * | 2005-07-01 | 2007-01-11 | Epigenomics Ag | Procede et acides nucleiques destines a un traitement ameliore des cancers |
WO2007032748A1 (fr) * | 2005-09-15 | 2007-03-22 | Agency For Science, Technology & Research | Procede de detection de la methylation de l'adn |
AU2006339538A1 (en) * | 2005-11-08 | 2007-09-13 | Euclid Diagnostics Llc | Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer |
US20070161006A1 (en) * | 2006-01-10 | 2007-07-12 | Vita Genomics, Inc. | Single nucleotide polymorphisms in protein-tyrosine phosphatase receptor-type delta for the diagnosis of susceptibility to infection and asthma |
WO2007095032A2 (fr) * | 2006-02-09 | 2007-08-23 | Novartis Ag | Mutations et polymorphismes du gène ptk2b |
US20070238115A1 (en) * | 2006-02-27 | 2007-10-11 | Dwinell Michael B | Method of Diagnosing and Treating Colon Cancer |
US7901882B2 (en) | 2006-03-31 | 2011-03-08 | Affymetrix, Inc. | Analysis of methylation using nucleic acid arrays |
US8084734B2 (en) * | 2006-05-26 | 2011-12-27 | The George Washington University | Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays |
US8067168B2 (en) | 2006-05-31 | 2011-11-29 | Orion Genomics Llc | Gene methylation in cancer diagnosis |
ES2599816T3 (es) * | 2006-07-21 | 2017-02-03 | Epigenomics Ag | Métodos relacionados con el gen GLI3 para la detección de cáncer colorrectal |
EP2487240B1 (fr) * | 2006-09-19 | 2016-11-16 | Interpace Diagnostics, LLC | Micro ARN différemment exprimés dans des maladies pancréatiques et leurs utilisations |
WO2008073915A2 (fr) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Microarn exprimés de manière différentielle en cas de leucémie et leurs utilisations |
GB0625321D0 (en) * | 2006-12-19 | 2007-01-24 | Univ Surrey | Cancer biomarker |
EP2103415B1 (fr) | 2007-01-18 | 2019-03-27 | Molecor Tecnología S.l. | Système de fabrication d'embouchures intégrées pour des conduites en plastique à orientation biaxiale |
US20090170081A1 (en) | 2007-02-02 | 2009-07-02 | Orion Genomics Llc | Gene methylation in bladder cancer diagnosis |
WO2008096146A1 (fr) | 2007-02-07 | 2008-08-14 | Solexa Limited | Préparation de matrices pour l'analyse de méthylation |
US20090131354A1 (en) * | 2007-05-22 | 2009-05-21 | Bader Andreas G | miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
EP2198050A1 (fr) | 2007-09-14 | 2010-06-23 | Asuragen, INC. | Microarn exprimés de manière différentielle dans le cancer du col de l'utérus et leurs utilisations |
WO2009052386A1 (fr) * | 2007-10-18 | 2009-04-23 | Asuragen, Inc. | Micro arn exprimés différentiellement dans des maladies pulmonaires et leurs utilisations |
WO2009070805A2 (fr) | 2007-12-01 | 2009-06-04 | Asuragen, Inc. | Gènes régulés par le mir-124 et cheminements servant de cibles pour une intervention thérapeutique |
WO2009108917A2 (fr) * | 2008-02-29 | 2009-09-03 | Oncomethylome Sciences, S.A. | Marqueurs pour la détection améliorée du cancer du sein |
EP2268832A2 (fr) * | 2008-03-06 | 2011-01-05 | Asuragen, INC. | Marqueurs microrna pour la récurrence d un cancer colorectal |
US8258111B2 (en) | 2008-05-08 | 2012-09-04 | The Johns Hopkins University | Compositions and methods related to miRNA modulation of neovascularization or angiogenesis |
WO2010048337A2 (fr) | 2008-10-22 | 2010-04-29 | Illumina, Inc. | Préservation d'informations liées à une méthylation d'adn génomique |
US8110796B2 (en) | 2009-01-17 | 2012-02-07 | The George Washington University | Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays |
CA2751688A1 (fr) * | 2009-02-06 | 2010-08-12 | Biao He | Emx2 en diagnostic et pronostic du cancer |
US9490113B2 (en) * | 2009-04-07 | 2016-11-08 | The George Washington University | Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry |
US20110086925A1 (en) * | 2009-06-09 | 2011-04-14 | Diego Mastroeni | Method and System to Detect, Diagnose, and Monitor the Progression of Alzheimer's Disease |
CA2777906A1 (fr) * | 2009-10-28 | 2011-05-05 | Signature Diagnostics Ag | Methode pour le pronostic du cancer des ovaires |
US9394570B2 (en) * | 2010-04-21 | 2016-07-19 | The Chinese University Of Hong Kong | Marker for colon cancer and method for detecting colon cancer |
DK2614952T3 (en) | 2010-09-06 | 2016-06-27 | Molecor Tecnologia Sl | DEVICES AND METHOD FOR PRODUCING mouths of biaxially oriented plastic pipe having INTEGRATED SEAL PACKAGING |
EP2630241B1 (fr) * | 2010-10-22 | 2018-10-17 | CuRNA, Inc. | Traitement de maladies associées à l'alpha-l-iduronidase (idua) par inhibition du transcrit antisens endogène de idua |
US10435743B2 (en) | 2011-05-20 | 2019-10-08 | The Regents Of The University Of California | Method to estimate age of individual based on epigenetic markers in biological sample |
EP2748333B1 (fr) * | 2011-08-25 | 2017-11-22 | Clinical Genomics Pty Ltd | Méthylation d'adn dans des procédés de diagnostic du cancer colorectal |
WO2013040251A2 (fr) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Méthodes et compositions incluant mir-135b, permettant de faire la distinction entre un cancer du pancréas et une maladie pancréatique bénigne |
US9127317B2 (en) | 2012-03-02 | 2015-09-08 | Winthrop-University Hospital | Method for using probe based PCR detection to measure the levels of circulating demethylated β cell derived DNA as a measure of β cell loss in diabetes |
WO2014071281A1 (fr) | 2012-11-02 | 2014-05-08 | The Johns Hopkins University | Biomarqueurs de méthylation de l'adn pour évaluer le risque de dépression survenant après l'accouchement |
ES2859645T3 (es) | 2013-03-14 | 2021-10-04 | Mayo Found Medical Education & Res | Detección de neoplasia |
ES2527724B1 (es) * | 2013-05-29 | 2015-11-10 | Fundación Para La Investigación Biomédica Del Hospital Universitario La Paz | Método para predecir la respuesta al tratamiento con radioterapia combinada con quimioterapia basada en cisplatino |
EP4234722A3 (fr) | 2014-03-31 | 2023-09-20 | Mayo Foundation for Medical Education and Research | Détection de néoplasme colorectal |
US9840742B2 (en) * | 2014-06-16 | 2017-12-12 | JBS Science Inc. | Detection of hepatitis B virus (HBV) DNA and methylated HBV DNA in urine of patients with HBV-associated hepatocellular carcinoma |
US10184154B2 (en) | 2014-09-26 | 2019-01-22 | Mayo Foundation For Medical Education And Research | Detecting cholangiocarcinoma |
US10030272B2 (en) | 2015-02-27 | 2018-07-24 | Mayo Foundation For Medical Education And Research | Detecting gastrointestinal neoplasms |
US20180230539A1 (en) * | 2015-07-21 | 2018-08-16 | Indiana University Research And Technology Corporation | Cell-free methylated and unmethylated dna in diseases resulting from abnormalities in blood glucose levels |
CA2992790A1 (fr) | 2015-08-31 | 2017-03-09 | Mayo Foundation For Medical Education And Research | Detection de neoplasme gastrique |
KR102380690B1 (ko) | 2016-04-14 | 2022-03-29 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | 췌장 고도 이형성증의 검출방법 |
US10370726B2 (en) | 2016-04-14 | 2019-08-06 | Mayo Foundation For Medical Education And Research | Detecting colorectal neoplasia |
CN105734152B (zh) * | 2016-04-20 | 2019-02-26 | 苏州吉诺瑞生物科技有限公司 | 检测人srpk2基因的表达水平的特异引物对及其应用 |
CN116064795A (zh) * | 2016-09-02 | 2023-05-05 | 梅约医学教育与研究基金会 | 确定差异甲基化区域的甲基化状态的方法和试剂盒 |
US20190284636A1 (en) * | 2016-10-26 | 2019-09-19 | Brown University | A method to measure myeloid suppressor cells for diagnosis and prognosis of cancer |
AU2018229294A1 (en) | 2017-02-28 | 2019-09-26 | Exact Sciences Corporation | Detecting prostate cancer |
KR20200105661A (ko) | 2017-11-30 | 2020-09-08 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | 유방암 검출방법 |
WO2019105090A1 (fr) * | 2017-12-01 | 2019-06-06 | 博尔诚(北京)科技有限公司 | Composition pour détecter le cancer de l'œsophage et utilisation associée |
CN108977457B (zh) * | 2018-08-31 | 2021-04-02 | 长江大学 | 一种黄鳝抗菌肽的制备方法 |
JP7320067B2 (ja) | 2019-01-18 | 2023-08-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 保存された遺伝子座に基づく、哺乳動物に関するdnaメチル化測定 |
DE102020111423B4 (de) | 2020-04-27 | 2022-03-03 | Precision For Medicine Gmbh | MYH11/NDE1 Region als epigenetischer Marker für die Identifizierung von Endothel-Vorläuferzellen (EPCs) |
US20240093318A1 (en) * | 2020-06-23 | 2024-03-21 | The Regents Of The University Of Colorado, A Body Corporate | Method for diagnosing respiratory pathogens and predicting covid-19 related outcomes |
EP4196611A1 (fr) | 2020-08-15 | 2023-06-21 | Regeneron Pharmaceuticals, Inc. | Traitement de l'obésité chez des sujets ayant des molécules d'acide nucléique variantes codant pour le récepteur de la calcitonine (calcr) |
WO2023175019A1 (fr) | 2022-03-15 | 2023-09-21 | Genknowme S.A. | Procédé pour déterminer la différence entre l'âge biologique et l'âge chronologique d'un sujet |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5843654A (en) * | 1992-12-07 | 1998-12-01 | Third Wave Technologies, Inc. | Rapid detection of mutations in the p53 gene |
US5837832A (en) * | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
EP0730663B1 (fr) * | 1993-10-26 | 2003-09-24 | Affymetrix, Inc. | Reseaux de sondes d'acide nucleique sur des microplaquettes biologiques |
US5804407A (en) * | 1993-11-04 | 1998-09-08 | University Technologies International, Inc. | Method of expressing genes in mammalian cells |
US5756668A (en) * | 1994-11-15 | 1998-05-26 | The Johns Hopkins University School Of Medicine | Hypermethylated in cancer polypeptide, HIC-1 |
US6017704A (en) * | 1996-06-03 | 2000-01-25 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
US6251594B1 (en) * | 1997-06-09 | 2001-06-26 | Usc/Norris Comprehensive Cancer Ctr. | Cancer diagnostic method based upon DNA methylation differences |
US6342350B1 (en) * | 1997-09-05 | 2002-01-29 | The General Hospital Corporation | Alpha-2-macroglobulin diagnostic test |
DE19754482A1 (de) * | 1997-11-27 | 1999-07-01 | Epigenomics Gmbh | Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke |
ATE217028T1 (de) * | 1997-12-05 | 2002-05-15 | Max Planck Gesellschaft | Verfahren zur identifikation von nucleinsäuren durch matrix-assistierte laser desorptions/ionisations massenspektrometrie |
DE19905082C1 (de) * | 1999-01-29 | 2000-05-18 | Epigenomics Gmbh | Verfahren zur Identifikation von Cytosin-Methylierungsmustern in genomischen DNA-Proben |
EP1283905A2 (fr) * | 2000-03-15 | 2003-02-19 | Epigenomics AG | Diagnostic d'affections associees au cycle cellulaire |
WO2001092565A2 (fr) * | 2000-04-06 | 2001-12-06 | Epigenomics Ag | Diagnostic de maladies associees a une transcription adn |
DE10128508A1 (de) * | 2001-06-14 | 2003-02-06 | Epigenomics Ag | Verfahren und Nukleinsäuren für die Differenzierung von Prostata-Tumoren |
EP1502222A2 (fr) * | 2001-07-02 | 2005-02-02 | Epigenomics AG | Systeme distribue pour prevision a base epigenetique de phenotypes complexes |
-
2001
- 2001-06-29 EP EP01969326A patent/EP1297185A2/fr not_active Withdrawn
- 2001-06-29 JP JP2002507050A patent/JP2004501666A/ja not_active Withdrawn
- 2001-06-29 WO PCT/EP2001/007470 patent/WO2002002806A2/fr not_active Application Discontinuation
- 2001-06-29 AU AU2001277521A patent/AU2001277521A1/en not_active Abandoned
- 2001-06-29 WO PCT/EP2001/007471 patent/WO2002002807A2/fr not_active Application Discontinuation
- 2001-06-29 US US10/257,166 patent/US20040023230A1/en not_active Abandoned
- 2001-06-29 AU AU2001289617A patent/AU2001289617A1/en not_active Abandoned
- 2001-06-29 EP EP01955325A patent/EP1297182A2/fr not_active Withdrawn
- 2001-06-29 EP EP01953995A patent/EP1294947A2/fr not_active Withdrawn
- 2001-06-29 WO PCT/EP2001/007472 patent/WO2002000926A2/fr not_active Application Discontinuation
- 2001-06-29 AU AU2001276371A patent/AU2001276371A1/en not_active Abandoned
- 2001-07-02 WO PCT/EP2001/007539 patent/WO2002000705A2/fr not_active Application Discontinuation
- 2001-07-02 WO PCT/EP2001/007537 patent/WO2002000928A2/fr active Application Filing
- 2001-07-02 EP EP01957909A patent/EP1294948A2/fr not_active Withdrawn
- 2001-07-02 US US10/311,455 patent/US20030143606A1/en not_active Abandoned
- 2001-07-02 WO PCT/EP2001/007540 patent/WO2002002809A2/fr not_active Application Discontinuation
- 2001-07-02 AU AU2001287576A patent/AU2001287576A1/en not_active Abandoned
- 2001-07-02 AU AU2001283915A patent/AU2001283915A1/en not_active Abandoned
- 2001-07-02 EP EP01967116A patent/EP1355932A2/fr not_active Withdrawn
- 2001-07-02 EP EP01967115A patent/EP1294951A2/fr not_active Withdrawn
- 2001-07-02 EP EP01962813A patent/EP1294950A2/fr not_active Ceased
- 2001-07-02 AU AU2001279707A patent/AU2001279707A1/en not_active Abandoned
- 2001-07-02 AU AU2001287575A patent/AU2001287575A1/en not_active Abandoned
- 2001-07-02 AU AU2001283916A patent/AU2001283916A1/en not_active Abandoned
- 2001-07-02 US US10/311,507 patent/US20040115630A1/en not_active Abandoned
- 2001-07-02 US US10/311,506 patent/US20080145839A1/en not_active Abandoned
- 2001-07-02 EP EP06002091A patent/EP1676927A3/fr not_active Withdrawn
- 2001-07-02 EP EP01962814A patent/EP1356099A2/fr not_active Withdrawn
- 2001-07-02 WO PCT/EP2001/007536 patent/WO2002000927A2/fr active Application Filing
- 2001-07-02 WO PCT/EP2001/007538 patent/WO2002002808A2/fr active Application Filing
-
2007
- 2007-08-07 US US11/835,336 patent/US20080026396A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001289617A1 (en) | Diagnosis of diseases associated with signal transduction | |
AU2002356324A1 (en) | Analysis of acoustic medical signals | |
HUP0301020A3 (en) | Early diagnosis of conformational diseases | |
AU2002212187A1 (en) | Diagnosis of illnesses or predisposition to certain illnesses | |
AU2002239370A1 (en) | Signal tampon | |
AU2003287735A1 (en) | Non-invasive measurement of analytes | |
AUPR005600A0 (en) | Diagnostic assay | |
AU2001288462A1 (en) | Medical instrument | |
AU2001232360A1 (en) | Medical instrument | |
AU2001227815A1 (en) | Chemically specific imaging of tissue | |
AU2001245382A1 (en) | Simultaneous multimodal measurement of physiological function | |
AU2001256020A1 (en) | Biological sounds monitor | |
AU2001277653A1 (en) | Diagnosis of known genetic parameters within the MHC | |
AU2002217091A1 (en) | Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis | |
AU2001264631A1 (en) | Medical instrument | |
AU2002218283A1 (en) | Diagnosis of diseases associated with cdk4 by determining the methyl delivery state of cdk4 | |
IL141950A0 (en) | Diagnosis of prion diseases | |
AU2001276874A1 (en) | Continuous preparation of polycarbonate | |
AU2002210438A1 (en) | Diagnosis of diseases which are associated with cd24 | |
AU2002226088A1 (en) | Enhanced diagnosis of psychiatric disorders with heartbeat data | |
AU3566200A (en) | Human signal transduction serine/threonine protein kinase | |
AU2002250041A1 (en) | Putative human enzymes | |
AU2003253850A1 (en) | NON-INVASIVE MEASUREMENT OF pH | |
AU2001249446A1 (en) | Diagnostic polymorphisms of tgf-beta-rii promoter | |
AUPQ048799A0 (en) | Diagnosis of cardiovascular disease |